High uric acid in the body can quietly create pain in joints, trigger gout, and affect daily movement. It forms when the body ...

Christopher “Click” Thompson is working the National Finals Rodeo after earning his fourth straight Photographer of the Year ...

The burden of cardiovascular-kidney-metabolic (CKM) comorbidities among adults with gout is high, noted Chio Yokose, MD, MSc, ...

Individuals with gout are more likely than those without the disease to receive chronic opioid therapy, independent of other ...

For $950 million upfront, Sobi will gain ownership to pozdeutinurad, an oral URAT1 inhibitor that performed well in Phase II ...

Samuela ‘Ofanoa, Ph.D., from the University of Auckland in New Zealand, and colleagues examined what types of gout content are on TikTok and assessed their association with user engagement. The ...

Patients with gout who receive 5 years of treat-to-target urate-lowering therapy achieve reductions in serum urate levels, ...

Fresh off a $153 million series E round, Arthrosi Therapeutics is skipping an IPO route and is instead being bought up for a ...

The deal revolves around a drug Sobi claimed could become the “therapy of choice” for people whose gout symptoms persist ...

Gout is a painful form of arthritis caused by a buildup of uric acid in the blood, which can cause sharp crystal deposits to form in the joints. A flare often begins suddenly, causing redness, ...

Drugmaker Swedish Orphan Biovitrum said on Saturday it had agreed to acquire U.S.-based biotechnology company Arthrosi Therapeutics for up to $1.5 billion to strengthen its portfolio of gout ...

Gut microbiota capable of metabolizing uric acid and purines may play a key role in reducing gout diagnoses, and although the findings from new retrospective and prospective studies suggest key roles ...